Imaging-guided interventions modulating portal venous flow: Evidence and controversies

Sanyal, 2008, Portal hypertension and its complications, Gastroenterology, 134, 1715, 10.1053/j.gastro.2008.03.007 Garcia-Tsao, 2017, Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases, Hepatology, 65, 310, 10.1002/hep.28906 Boyer, 2010, The role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the management of portal hypertension: update 2009, Hepatology, 51, 306, 10.1002/hep.23383 2018, EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis, J Hepatol, 69, 406, 10.1016/j.jhep.2018.03.024 Tripathi, 2020, Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension, Gut, 69, 1173, 10.1136/gutjnl-2019-320221 de Franchis, 2021, Baveno VII - renewing consensus in portal hypertension, J Hepatol Biggins, 2021, Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases, Hepatology, 74, 1014, 10.1002/hep.31884 Saad, 2013, Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome, AJR Am J Roentgenol, 200, 210, 10.2214/AJR.11.7653 Sarwar, 2018, Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States, Hepatology, 67, 690, 10.1002/hep.29354 Fidelman, 2012, The transjugular intrahepatic portosystemic shunt: an update, AJR Am J Roentgenol, 199, 746, 10.2214/AJR.12.9101 Keller, 2016, The transjugular intrahepatic portosystemic shunt: technique and instruments, Tech Vasc Interv Radiol, 19, 2, 10.1053/j.tvir.2016.01.001 Artru, 2022, Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: indications, technique, and outcomes beyond Budd-Chiari syndrome, Clin Res Hepatol Gastroenterol, 101858, 10.1016/j.clinre.2022.101858 Zhang, 2021, EUS-guided portal pressure gradient measurement in patients with acute or subacute portal hypertension, Gastrointest Endosc, 93, 565, 10.1016/j.gie.2020.06.065 Silva-Junior, 2017, Timing affects measurement of portal pressure gradient after placement of transjugular intrahepatic portosystemic shunts in patients with portal hypertension, Gastroenterology, 152, 1358, 10.1053/j.gastro.2017.01.011 Sommer, 2012, Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus viatorr stent-grafts (VSG), Eur J Radiol, 81, 2273, 10.1016/j.ejrad.2011.06.037 Gupta, 2017, Added value of covered stents in transjugular intrahepatic portosystemic shunt: a large single-center experience, Cardiovasc Intervent Radiol, 40, 1723, 10.1007/s00270-017-1694-1 2010, EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis, J Hepatol, 53, 397, 10.1016/j.jhep.2010.05.004 Madoff, 2021, Management of refractory ascites due to portal hypertension: current status, Radiology, 298, 493, 10.1148/radiol.2021201960 Salerno, 2007, Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data, Gastroenterology, 133, 825, 10.1053/j.gastro.2007.06.020 Bureau, 2011, Serum bilirubin and platelet count: a simple predictive model for survival in patients with refractory ascites treated by TIPS, J Hepatol, 54, 901, 10.1016/j.jhep.2010.08.025 Sauerbruch, 2015, Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy, Gastroenterology, 149, 660, 10.1053/j.gastro.2015.05.011 Holster, 2016, Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding, Hepatology, 63, 581, 10.1002/hep.28318 Niekamp, 2020, Transjugular intrahepatic portosystemic shunts reduce variceal bleeding and improve survival in patients with cirrhosis: a population-based analysis, J Vasc Interv Radiol, 31, 1382, 10.1016/j.jvir.2020.06.005 Azoulay, 2001, Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis, J Hepatol, 35, 590, 10.1016/S0168-8278(01)00185-4 Vangeli, 2002, Salvage tips for uncontrolled variceal bleeding, J Hepatol, 37, 703, 10.1016/S0168-8278(02)00321-5 García-Pagán, 2010, Early use of TIPS in patients with cirrhosis and variceal bleeding, N Engl J Med, 362, 2370, 10.1056/NEJMoa0910102 Rudler, 2014, Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival, Aliment Pharmacol Ther, 40, 1074, 10.1111/apt.12934 Bucsics, 2017, Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice, Dig Liver Dis, 49, 1360, 10.1016/j.dld.2017.08.002 Hernández-Gea, 2019, Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study, Hepatology, 69, 282, 10.1002/hep.30182 Dunne, 2020, Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding, Aliment Pharmacol Ther, 52, 98, 10.1111/apt.15797 Trebicka, 2021, PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis, J Hepatol, 74, 1097, 10.1016/j.jhep.2020.11.019 Trebicka, 2020, Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS, J Hepatol, 73, 1082, 10.1016/j.jhep.2020.04.024 Luca, 2011, Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis, Gut, 60, 846, 10.1136/gut.2010.228023 Qi, 2016, Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study, Liver Int, 36, 667, 10.1111/liv.12929 Lv, 2017, Association of nonmalignant portal vein thrombosis and outcomes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis, Radiology, 285, 999, 10.1148/radiol.2017162266 Wang, 2016, Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? a randomized controlled trial, Radiology, 279, 943, 10.1148/radiol.2015150369 Fares, 2018, Transjugular intrahepatic portosystemic shunt placement before abdominal intervention in cirrhotic patients with portal hypertension: lessons from a pilot study, Eur J Gastroenterol Hepatol, 30, 21, 10.1097/MEG.0000000000000990 Lahat, 2018, Transjugular intrahepatic portosystemic shunt as a bridge to non-hepatic surgery in cirrhotic patients with severe portal hypertension: a systematic review, HPB (Oxford), 20, 101, 10.1016/j.hpb.2017.09.006 Tabchouri, 2019, Original study: transjugular intrahepatic portosystemic shunt as a bridge to abdominal surgery in cirrhotic patients, J Gastrointest Surg, 23, 2383, 10.1007/s11605-018-4053-x Reverter, 2019, The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery, J Hepatol, 71, 942, 10.1016/j.jhep.2019.07.007 Geeroms, 2017, Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: long-term patency and clinical outcome results, Eur Radiol, 27, 1795, 10.1007/s00330-016-4570-5 Gaba, 2011, Comprehensive review of TIPS technical complications and how to avoid them, AJR Am J Roentgenol, 196, 675, 10.2214/AJR.10.4819 Vozzo, 2019, Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience, Gastroenterol Rep (Oxf), 8, 98, 10.1093/gastro/goz062 Sarwar, 2020, Causes and rates of 30-day readmissions after transjugular intrahepatic portosystemic shunts, AJR Am J Roentgenol, 215, 235, 10.2214/AJR.19.21732 Coronado, 2020, Predictors of occurrence and risk of hepatic encephalopathy after TIPS creation: a 15-year experience, Cardiovasc Intervent Radiol, 43, 1156, 10.1007/s00270-020-02512-7 Khan, 2021, Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement, J Gastroenterol Hepatol, 36, 775, 10.1111/jgh.15194 Bureau, 2021, The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt : a randomized controlled trial, Ann Intern Med, 174, 633, 10.7326/M20-0202 Pereira, 2016, Endovascular management of refractory hepatic encephalopathy complication of transjugular intrahepatic portosystemic shunt (TIPS): comprehensive review and clinical practice algorithm, Cardiovasc Intervent Radiol, 39, 170, 10.1007/s00270-015-1197-x Borentain, 2016, The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement, Diagn Interv Imaging, 97, 643, 10.1016/j.diii.2016.02.004 Bettinger, 2021, Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival, J Hepatol, 74, 1362, 10.1016/j.jhep.2021.01.023 Praktiknjo, 2019, Sarcopenia is associated with development of acute-on-chronic liver failure in decompensated liver cirrhosis receiving transjugular intrahepatic portosystemic shunt, Clin Transl Gastroenterol, 10, 10.14309/ctg.0000000000000025 Billey, 2019, A prospective study identifying predictive factors of cardiac decompensation after transjugular intrahepatic portosystemic shunt: the toulouse algorithm, Hepatology, 70, 1928, 10.1002/hep.30934 Perarnau, 2014, Covered vs.. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial, J Hepatol, 60, 962, 10.1016/j.jhep.2014.01.015 Saad, 2013, Ectopic varices: anatomical classification, hemodynamic classification, and hemodynamic-based management, Tech Vasc Interv Radiol, 16, 158, 10.1053/j.tvir.2013.02.004 Vidal, 2006, Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients, Cardiovasc Intervent Radiol, 29, 216, 10.1007/s00270-004-0346-4 Vangeli, 2004, Bleeding ectopic varices--treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation, J Hepatol, 41, 560, 10.1016/j.jhep.2004.06.024 Oey, 2018, Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study, Aliment Pharmacol Ther, 48, 975, 10.1111/apt.14947 Deipolyi, 2014, Reduction in portal venous pressure by transjugular intrahepatic portosystemic shunt for treatment of hemorrhagic stomal varices, AJR Am J Roentgenol, 203, 668, 10.2214/AJR.13.12211 Bai, 2014, EVS vs. TIPS shunt for gastric variceal bleeding in patients with cirrhosis: a meta-analysis, World J Gastrointest Pharmacol Ther, 5, 97, 10.4292/wjgpt.v5.i2.97 Lv, 2019, Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study, Gut, 68, 1297, 10.1136/gutjnl-2018-317057 Nicoară-Farcău, 2021, Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data, Gastroenterology, 160, 193, 10.1053/j.gastro.2020.09.026 Thabut, 2017, Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results, J Hepatol, 68, 73, 10.1016/j.jhep.2017.09.002 Kim, 2020, ACR appropriateness criteria® radiologic management of gastric varices, J Am Coll Radiol, 17, S239, 10.1016/j.jacr.2020.01.017 Liu, 2020, The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage, Eur J Gastroenterol Hepatol, 32, 656, 10.1097/MEG.0000000000001705 Paleti, 2020, Balloon-occluded retrograde transvenous obliteration (BRTO) versus transjugular intrahepatic portosystemic shunt (TIPS) for treatment of gastric varices because of portal hypertension: a systematic review and meta-analysis, J Clin Gastroenterol, 54, 655, 10.1097/MCG.0000000000001275 Saad, 2014, Combining transjugular intrahepatic portosystemic shunt with balloon-occluded retrograde transvenous obliteration or augmenting TIPS with variceal embolization for the management of gastric varices: an evolving middle ground?, Semin Intervent Radiol, 31, 266, 10.1055/s-0034-1382796 Loffroy, 2015, Transjugular intrahepatic portosystemic shunt for acute variceal gastrointestinal bleeding: indications, techniques and outcomes, Diagn Interv Imaging, 96, 745, 10.1016/j.diii.2015.05.005 Yu, 2019, Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study, Eur Radiol, 29, 699, 10.1007/s00330-018-5645-2 Chen, 2013, Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization, Radiology, 268, 900, 10.1148/radiol.13120800 Qi, 2014, Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis, J Gastroenterol Hepatol, 29, 688, 10.1111/jgh.12391 Wan, 2019, Comparison of TIPS alone and combined with partial splenic embolization (PSE) for the management of variceal bleeding, Eur Radiol, 29, 5032, 10.1007/s00330-019-06046-6 Li, 2020, The effect of transjugular intrahepatic portosystemic shunt plus partial splenic embolization for the treatment of patients with recurrent variceal bleeding, Acad Radiol, 27, 323, 10.1016/j.acra.2019.04.013 Bosch, 2021, Small diameter shunts should lead to safe expansion of the use of TIPS, J Hepatol, 74, 230, 10.1016/j.jhep.2020.09.018 Chung, 2008, Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?, J Gastroenterol Hepatol, 23, 95, 10.1111/j.1440-1746.2006.04697.x Riggio, 2010, Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial, J Hepatol, 53, 267, 10.1016/j.jhep.2010.02.033 Miraglia, 2017, Transjugular intrahepatic portosystemic shunts in patients with cirrhosis with refractory ascites: comparison of clinical outcomes by using 8- and 10-mm PTFE-covered stents, Radiology, 284, 281, 10.1148/radiol.2017161644 Trebicka, 2019, Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival, Clin Gastroenterol Hepatol, 17, 2793, 10.1016/j.cgh.2019.03.042 Luo, 2019, Clinical efficacy of transjugular intrahepatic portosystemic shunt created with expanded polytetrafluoroethylene-covered stent-grafts: 8-mm versus 10-mm, Cardiovasc Intervent Radiol, 42, 737, 10.1007/s00270-019-02162-4 Huang, 2021, Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) created using covered stents of different diameters: a systematic review and meta-analysis, Diagn Interv Imaging, 102, 279, 10.1016/j.diii.2020.11.004 Praktiknjo, 2021, Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation, JHEP Rep, 3, 100264, 10.1016/j.jhepr.2021.100264 Bissonnette, 2016, Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension, Hepatology, 64, 224, 10.1002/hep.28547 Luo, 2014, Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension in noncirrhotic patients with portal cavernoma, Gastroenterol Res Pract, 2014, 659726, 10.1155/2014/659726 Fanelli, 2011, Transjugular intrahepatic portosystemic shunt with expanded-polytetrafuoroethylene-covered stents in non-cirrhotic patients with portal cavernoma, Dig Liver Dis, 43, 78, 10.1016/j.dld.2010.06.001 Qi, 2012, Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients, Dig Dis Sci, 57, 1072, 10.1007/s10620-011-1975-5 Knight, 2021, TIPS for adults without cirrhosis with chronic mesenteric venous thrombosis and EHPVO refractory to standard-of-care therapy, Hepatology, 74, 2735, 10.1002/hep.31915 Yadav, 2018, Percutaneous transhepatic approach for recanalization of superior mesenteric and portal vein in a patient with pancreatic neuroendocrine tumor presenting with bleeding duodenal varices: a brief case report, J Clin Exp Hepatol, 8, 318, 10.1016/j.jceh.2018.03.003 Rodrigues, 2018, Imaging and minimally invasive endovascular therapy in the management of portal vein thrombosis, Abdom Radiol (NY), 43, 1931, 10.1007/s00261-017-1335-9 Marot, 2019, Percutaneous portal vein recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion, Diagn Interv Imaging, 100, 147, 10.1016/j.diii.2018.07.009 Kim, 2011, Percutaneous transhepatic stent placement in the management of portal venous stenosis after curative surgery for pancreatic and biliary neoplasms, AJR Am J Roentgenol, 196, W446, 10.2214/AJR.10.5274 Valla, 2020, Recent developments in the field of vascular liver diseases, Liver Int, 40, 142, 10.1111/liv.14348 Kim, 2019, Stent insertion and balloon angioplasty for portal vein stenosis after liver transplantation: long-term follow-up results, Diagn Interv Radiol, 25, 231, 10.5152/dir.2019.18155 Sare, 2021, Safety and efficacy of endovascular treatment of portal vein stenosis in liver transplant recipients: a systematic review, Vasc Endovasc Surg, 55, 452, 10.1177/1538574421994417 Luo, 2011, Endovascular treatment for nonacute symptomatic portal venous thrombosis through intrahepatic portosystemic shunt approach, J Vasc Interv Radiol, 22, 61, 10.1016/j.jvir.2010.07.028 Hall, 2011, Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review, World J Surg, 35, 2510, 10.1007/s00268-011-1198-0 Rössle, 2020, A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatment, Aliment Pharmacol Ther, 52, 329, 10.1111/apt.15811 Woodrum, 2009, Portal vein venoplasty and stent placement in the nontransplant population, J Vasc Interv Radiol, 20, 593, 10.1016/j.jvir.2009.02.010 Hasegawa, 2015, Portal venous stent placement for malignant portal venous stenosis or occlusion: who benefits?, Cardiovasc Intervent Radiol, 38, 1515, 10.1007/s00270-015-1123-2 Thornburg, 2016, Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations, Tech Vasc Interv Radiol, 19, 52, 10.1053/j.tvir.2016.01.006 Rosenqvist, 2016, Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver, Acta Radiol, 57, 572, 10.1177/0284185115595060 Salem, 2015, Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis, Transplantation, 99, 2347, 10.1097/TP.0000000000000729 Barbier, 2020, Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions - a retrospective evaluation, Acta Radiol Open, 9 Habib, 2015, Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis, J Vasc Interv Radiol, 26, 499, 10.1016/j.jvir.2014.12.012 Thornburg, 2017, Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort, J Vasc Interv Radiol, 28, 1714, 10.1016/j.jvir.2017.08.005 Vauthey, 2010, Pretreatment assessment of hepatocellular carcinoma: expert consensus statement, HPB (Oxford), 12, 289, 10.1111/j.1477-2574.2010.00181.x Denys, 2012, Portal vein embolization: what do we know?, Cardiovasc Intervent Radiol, 35, 999, 10.1007/s00270-011-0300-1 Downing, 2018, Portal venous interventions: how to recognize, avoid, or get out of trouble in transjugular intrahepatic portosystemic shunt (TIPS), balloon occlusion sclerosis (ie, BRTO), and portal vein embolization (PVE), Tech Vasc Interv Radiol, 21, 267, 10.1053/j.tvir.2018.07.009 van Lienden, 2013, Portal vein embolization before liver resection: a systematic review, Cardiovasc Intervent Radiol, 36, 25, 10.1007/s00270-012-0440-y Ishizawa, 2007, Selective versus total biliary drainage for obstructive jaundice caused by a hepatobiliary malignancy, Am J Surg, 193, 149, 10.1016/j.amjsurg.2006.07.015 Hameed, 2016, Percutaneous vs.. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a systematic review and meta-analysis, HPB (Oxford), 18, 400, 10.1016/j.hpb.2016.03.002 Miura, 2020, Preoperative biliary drainage of the hepatic lobe to be resected does not affect liver hypertrophy after percutaneous transhepatic portal vein embolization, Surg Endosc, 34, 667, 10.1007/s00464-019-06813-y Isfordink, 2017, Portal vein ligation versus portal vein embolization for induction of hypertrophy of the future liver remnant: a systematic review and meta-analysis, Surg Oncol, 26, 257, 10.1016/j.suronc.2017.05.001 Schnitzbauer, 2012, Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings, Ann Surg, 255, 405, 10.1097/SLA.0b013e31824856f5 Truant, 2015, Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management, Eur J Surg Oncol, 41, 674, 10.1016/j.ejso.2015.01.004 Buac, 2016, The many faces of ALPPS: surgical indications and techniques among surgeons collaborating in the international registry, HPB (Oxford), 18, 442, 10.1016/j.hpb.2016.01.547 Eshmuminov, 2016, Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy, Br J Surg, 103, 1768, 10.1002/bjs.10290 Shindoh, 2014, Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients, J Gastrointest Surg, 18, 45, 10.1007/s11605-013-2369-0 Glantzounis, 2017, The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review, Eur J Surg Oncol, 43, 32, 10.1016/j.ejso.2016.05.026 Ironside, 2017, Systematic review of perioperative and survival outcomes of liver resections with and without preoperative portal vein embolization for colorectal metastases, HPB (Oxford), 19, 559, 10.1016/j.hpb.2017.03.003 Shindoh, 2013, Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival, Br J Surg, 100, 1777, 10.1002/bjs.9317 Ogata, 2006, Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma, Br J Surg, 93, 1091, 10.1002/bjs.5341 Yoo, 2011, Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma, Ann Surg Oncol, 18, 1251, 10.1245/s10434-010-1423-3 Ronot, 2016, Sequential transarterial chemoembolization and portal vein embolization before resection is a valid oncological strategy for unilobar hepatocellular carcinoma regardless of the tumor burden, HPB (Oxford), 18, 684, 10.1016/j.hpb.2016.05.012 Bekki, 2021, A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma, Surgery, 169, 1044, 10.1016/j.surg.2020.12.012 Garlipp, 2014, Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization, Hepatology, 59, 1864, 10.1002/hep.26947 Di Stefano, 2005, Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients, Radiology, 234, 625, 10.1148/radiol.2342031996 Yeom, 2015, Complications of portal vein embolization: evaluation on cross-sectional imaging, Korean J Radiol, 16, 1079, 10.3348/kjr.2015.16.5.1079 Guiu, 2013, Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils, Cardiovasc Intervent Radiol, 36, 1306, 10.1007/s00270-013-0565-7 Dhaliwal, 2018, Portal vein embolization: correlation of future liver remnant hypertrophy to type of embolic agent used, Can Assoc Radiol J, 69, 316, 10.1016/j.carj.2018.02.003 Jaberi, 2016, Comparison of clinical outcomes following glue versus polyvinyl alcohol portal vein embolization for hypertrophy of the future liver remnant prior to right hepatectomy, J Vasc Interv Radiol, 27, 1897, 10.1016/j.jvir.2016.05.023 Sugawara, 2019, Retrospective comparative study of absolute ethanol with N-Butyl-2-Cyanoacrylate in percutaneous portal vein embolization, J Vasc Interv Radiol, 30, 1215, 10.1016/j.jvir.2018.12.020 Ali, 2021, Portal vein embolization with N-butyl cyanoacrylate glue is superior to other materials: a systematic review and meta-analysis, Eur Radiol, 31, 5464, 10.1007/s00330-020-07685-w Luz, 2021, BestFLR trial: liver regeneration at CT before major hepatectomies for liver cancer-A randomized controlled trial comparing portal vein embolization with N-butyl-cyanoacrylate plus iodized oil versus polyvinyl alcohol particles plus coils, Radiology, 299, 715, 10.1148/radiol.2021204055 Malinowski, 2015, Factors influencing hypertrophy of the left lateral liver lobe after portal vein embolization, Langenbecks Arch Surg, 400, 237, 10.1007/s00423-014-1266-7 Fischer, 2013, Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy, JAMA Surg, 148, 1103, 10.1001/jamasurg.2013.2126 Zorzi, 2008, Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases, Ann Surg Oncol, 15, 2765, 10.1245/s10434-008-0035-7 Aussilhou, 2009, Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab, Ann Surg Oncol, 16, 1553, 10.1245/s10434-009-0447-z Guiu, 2016, Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique, Eur Radiol, 26, 4259, 10.1007/s00330-016-4291-9 Laurent, 2020, Radiological simultaneous portohepatic vein embolization (RASPE) before major hepatectomy: a better way to optimize liver hypertrophy compared to portal vein embolization, Ann Surg, 272, 199, 10.1097/SLA.0000000000003905 Hocquelet, 2018, Preoperative portal vein embolization alone with biliary drainage compared to a combination of simultaneous portal vein, right hepatic vein embolization and biliary drainage in Klatskin tumor, Cardiovasc Intervent Radiol, 41, 1885, 10.1007/s00270-018-2075-0 Kobayashi, 2020, Liver venous deprivation compared to portal vein embolization to induce hypertrophy of the future liver remnant before major hepatectomy: a single center experience, Surgery, 167, 917, 10.1016/j.surg.2019.12.006 Le Roy, 2020, Combined biembolization induces higher hypertrophy than portal vein embolization before major liver resection, HPB (Oxford), 22, 298, 10.1016/j.hpb.2019.08.005 Esposito, 2019, Combined hepatic and portal vein embolization as preparation for major hepatectomy: a systematic review, HPB (Oxford), 21, 1099, 10.1016/j.hpb.2019.02.023 Guiu, 2017, Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function, Eur Radiol, 27, 3343, 10.1007/s00330-017-4744-9 Khayat, 2021, Oncological outcomes after liver venous deprivation for colorectal liver metastases: a single center experience, Cancers (Basel), 13, 200, 10.3390/cancers13020200 Deshayes, 2020, BMC Cancer, 20, 574, 10.1186/s12885-020-07065-z Piron, 2020, Deportalization, venous congestion, venous deprivation: serial measurements of volumes and functions on morphofunctional 99mTc-mebrofenin SPECT-CT, Diagnostics (Basel), 11, 12, 10.3390/diagnostics11010012 Guiu, 2020, Liver venous deprivation versus portal vein embolization before major hepatectomy: future liver remnant volumetric and functional changes, Hepatobiliary Surg Nutr, 9, 564, 10.21037/hbsn.2020.02.06 Kishi, 2008, Is embolization of segment 4 portal veins before extended right hepatectomy justified?, Surgery, 144, 744, 10.1016/j.surg.2008.05.015 Björnsson, 2020, Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - a Scandinavian cohort study, Int J Surg, 75, 60, 10.1016/j.ijsu.2020.01.129 Ito, 2020, Evaluation of segment 4 portal vein embolization added to right portal vein for right hepatic trisectionectomy: a retrospective propensity score-matched study, J Hepatobiliary Pancreat Sci, 27, 299, 10.1002/jhbp.723 Hammond, 2019, Segment 2/3 hypertrophy is greater when right portal vein embolisation is extended to segment 4 in patients with colorectal liver metastases: a retrospective cohort study, Cardiovasc Intervent Radiol, 42, 552, 10.1007/s00270-018-02159-5 Alvarez, 2018, Natural history of portal vein embolization before liver resection: a 23-year analysis of intention-to-treat results, Surgery, 163, 1257, 10.1016/j.surg.2017.12.027 Loveday, 2019, Effect of portal vein embolization on treatment plan prior to major hepatectomy for hepatocellular carcinoma, HPB (Oxford), 21, 1072, 10.1016/j.hpb.2018.12.009 Lim, 2013, Tumour progression and liver regeneration--insights from animal models, Nat Rev Gastroenterol Hepatol, 10, 452, 10.1038/nrgastro.2013.55 Simoneau, 2012, Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases, HPB (Oxford), 14, 461, 10.1111/j.1477-2574.2012.00476.x Imai, 2019, Is disease progression a contraindication for the strategy of portal vein embolization followed by hepatectomy for hepatocellular carcinoma?, Surgery, 165, 696, 10.1016/j.surg.2018.10.023 Giglio, 2016, Oncological outcomes of major liver resection following portal vein embolization: a systematic review and meta-analysis, Ann Surg Oncol, 23, 3709, 10.1245/s10434-016-5264-6 Pommier, 2014, Colorectal liver metastases growth in the embolized and non-embolized liver after portal vein embolization: influence of initial response to induction chemotherapy, Ann Surg Oncol, 21, 3077, 10.1245/s10434-014-3700-z Spelt, 2015, Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases, HPB (Oxford), 17, 529, 10.1111/hpb.12397